Wessex Care sees light in UV-C Covid decontamination tech

Wessex Care has become the first provider in the UK to commission an ultraviolet-C (UV-C) light decontamination technology in the fight against the coronavirus.

The Salisbury provider has deployed an Ultra-V device - a remote-controlled mobile decontamination robot - developed by infection prevention and control company Inivos.

The device is designed to eradicate pathogens including SARS-CoV-2, which causes the Covid-19 virus.

Inivos claims the UV-C light technology can reduce viruses and bacteria to safe, non-infective levels in eight minutes by breaking down their genetic code.

Ultra-V provides validation reports at the end of each cycle to inform operators that a decontaminated area is safe for residents.

“We’re so pleased that Wessex Care have taken the step to commission Ultra-V in their facilities. Our ultraviolet-C and hydrogen peroxide vapour technologies are already used by more than a third of NHS Trusts,” said Invios head of research and development Tautvydas Karitonas.

“However, we believe that clinical decontamination technology will soon become the norm in care homes as forward-thinking providers like Wessex look to secure best-in-class technology to ensure the continued health and wellbeing of their patients during this pandemic,” he added.

Wessex Care founding director Matthew Airey said: “We’re proud to be the first care provider to take this step meaning our staff, patients and their loved ones can continue to be confident in the quality of care provided at Wessex.

Latest Issues

Care Sector Supplier Awards

London Marriott Hotel Canary Wharf, 22 Hertsmere Rd, London E14 4ED
29th April 2025

Care Show London

ExCel, London
30 April 2025 - 1 May 2025

Care Roadshows - Liverpool

Aintree Racecourse, Liverpool
13th May 2025

Care Roadshows - Birmingham

Villa Park Stadium, Birmingham
15th May 2025

LaingBuisson Social Care Summit

etc.venues, St. Paul's, London
Thursday 5th June 2025

Care Innovation Summit

Business Design Centre, London.
19th June 2025